Activation of p53/miR-34a Tumor Suppressor Axis by Chinese Herbal Formula JP-1 in A549 Lung Adenocarcinoma Cells

Abstract

Lung cancer is the leading cause of cancer death worldwide; the most common pathologic type is lung adenocarcinoma (LADC). In spite of the recent progress in targeted therapy, most LADC patients eventually expired due to the inevitable recurrence and drug resistance. New complementary agent with evidence-based molecular mechanism is urgently needed. MiR-34a is an important p53 downstream tumor suppressor, which regulates apoptosis, cell-cycle, EMT (epithelial mesenchymal transition), and so forth. Its expression is deficient in many types of cancers including LADC. Here, we show that a Chinese herbal formula JP-1 activates p53/miR-34a axis in A549 human LADC cells (p53 wild-type). Treatment with JP-1 induces p53 and its downstream p21 and BAX proteins as well as the miR-34a, resulting in growth inhibition, colony formation reduction, migration repression, and apoptosis induction. Accordingly, the decreases of miR-34a downstream targets such as CDK6, SIRT1, c-Myc, survivin, Snail, and AXL were observed. Moreover, JP-1 activates AMPKα and reduces mTOR activity, implying its inhibitory effect on the energy-sensitive protein synthesis and cell proliferation signaling. Our results show that JP-1 activates p53/miR-34a tumor suppressor axis and decreases proteins related to proliferation, apoptosis resistance, and metastasis, suggesting its potential as a complementary medicine for LADC treatment.

Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA-Damaging Agents: Implications for Oncolytic Virus Therapy

“…We have found that the combination of P/V-CPI Ϫ and cisplatin is effective in HEp-2 ( Fig. 3) and A549 human non-small-cell lung carcinoma cells (data not shown), both of which have wild-type p53 (52,53). Future studies will determine the roles of wild-type versus mutated p53 and WIP1 in P/V-CPI Ϫ -enhanced sensitivity to cisplatin.…”

MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2

“…Welch found that mir-34a can inhibit cell proliferation and promotes apoptosis in medulloblastoma cells. 8 This phenomenon also exists in pancreatic cancer cells, 6 in prostate cancer cells, 9,10 in head and neck squamous cell carcinoma, 11 in laryngeal squamous cell carcinoma, 12 in uveal melanoma cell, 13 in gastric cancer cell, 14 in human hepatocellular carcinoma cells, 15 in lung cancer cell, 16 and in colon cancer cell, 17 and it is also found by Li et al 18 that MiR-34a inhibits proliferation and migration of breast cancer through downregulation of Bcl-2 and SIRT1. Wang et al 19 also found that overexpression of miR-34a reduces ErbB2 expression and suppresses breast cancer cell invasion and growth.…”

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

“…The Chinese herbal formulation JP-1 activates p53 and downstream p21 and BAX proteins in addition to miR-34a in A549 lung adenocarcinoma cells, leading to inhibition of proliferation, induction of apoptosis, a reduction in colony formation, and repression of migration. 196 It has been suggested that miR-34a is a master p53 downstream tumor suppressor in cancer, participating in cell cycle arrest, resistance to apoptosis, and progression of epithelial-mesenchymal transition (EMT). 197,198 Curcumin induces apoptosis in multiple myeloma via modulation of the EZH2-miR-101 regulatory feedback loop.…”